| WESLEYAN UNIVERSITY Patent applications |
| Patent application number | Title | Published |
|---|
| 20120123059 | FUNCTIONALIZED POLYMERS AND METHODS OF MAKING - Disclosed herein are copolymers comprising functional groups attached to the backbone of the polymer and methods of making these polymers. | 05-17-2012 |
| 20110059854 | DIAGNOSTIC AND PROGNOSTIC TESTS - The invention provides methods for diagnosing biological states or conditions based on ratios of gene expression data from tissue samples, such as cancer tissue samples. The invention also provides sets of genes that are expressed differentially in malignant pleural mesothelioma. These sets of genes can be used to discriminate between normal and malignant tissues, and between classes of malignant tissues. Accordingly, diagnostic assays for classification of tumors, prediction of tumor outcome, selecting and monitoring treatment regimens and monitoring tumor progression/regression also are provided. | 03-10-2011 |
| 20100134631 | APPARATUS AND METHOD FOR REAL TIME IMAGE COMPRESSION FOR PARTICLE TRACKING - A real-time image compression method includes identifying pixels in a set of image data that have a brightness value past a predetermined threshold; determining a position of each identified pixel in the image data; and for each of the identified pixels, defining a vector that includes the brightness value and the position of the identified pixel in the image data. | 06-03-2010 |
| 20090104617 | Diagnostic and Prognostic Tests - The invention provides methods for diagnosing biological states or conditions based on ratios of gene expression data from tissue samples, such as cancer tissue samples. The invention also provides sets of genes that are expressed differentially in malignant pleural mesothelioma. These sets of genes can be used to discriminate between normal and malignant tissues, and between classes of malignant tissues. Accordingly, diagnostic assays for classification of tumors, prediction of tumor outcome, selecting and monitoring treatment regimens and monitoring tumor progression/regression also are provided. | 04-23-2009 |
